Manufacturers Life Insurance Company, The Infinity Pharmaceuticals, Inc. Transaction History

Manufacturers Life Insurance Company, The

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.49 - $1.2 $11,370 - $27,847	-23,206 Closed	0 $0
Q1 2022 Aug 11, 2023	BUY	$0.85 - $2.4 $19,725 - $55,694	23,206 New	23,206 $26,000
Q1 2022 May 20, 2022	SELL	$0.85 - $2.4 $23,032 - $65,032	-27,097 Reduced 53.87%	23,206 $26,000
Q4 2021 Feb 16, 2022	BUY	$1.86 - $3.36 $976 - $1,764	525 Added 1.05%	50,303 $113,000
Q3 2021 Nov 12, 2021	SELL	$1.52 - $3.82 $6,324 - $15,895	-4,161 Reduced 7.71%	49,778 $170,000
Q2 2021 Aug 12, 2021	BUY	$2.66 - $3.47 $143,477 - $187,168	53,939 New	53,939 $161,000
Q3 2018 Nov 14, 2018	SELL	$1.72 - $2.71 $4,520 - $7,121	-2,628 Closed	0 $0
Q4 2017 Feb 08, 2018	BUY	$1.22 - $3.73 $3,206 - $9,802	2,628	2,628 $5,000

1.26M

Ticker INFI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 89,277,904
Description
Infinity Pharmaceuticals, Inc., a biopharmaceutical company, focuses on developing novel medicines for people with cancer. Its product candidate is IPI-549, an orally administered clinical-stage immuno-oncology product candidate that inhibits the enzyme phosphoinositide-3-kinase-gamma, which is in Phase 2 clinical trials for the treatment of met...

Get notified when there are updates to the investment portfolio of Manufacturers Life Insurance Company, The, based on Form 13F filings with the SEC.

Stay updated on Manufacturers Life Insurance Company, The with notifications on news.